• 1 year ago
Washington is preparing to impose a 100% tariff on imported, patent-protected pharmaceuticals starting in October — unless manufacturers in Europe and elsewhere relocate production to American soil.

Category

🗞
News
Transcript
00:00The United States is the world's biggest pharmaceutical market and it is lucrative.
00:07Drug makers can sell their medication at considerably higher prices compared to other industrialized
00:13countries.
00:14US President Donald Trump wants to change that.
00:18The White House already sent letters to the leaders of 17 pharma companies demanding they
00:24slash prices by the end of September.
00:27And now the US president is going a step further.
00:31Starting Tuesday, patented pharmaceuticals will be subjected to a 100% tariff in the US
00:38unless they build a manufacturing plant in the United States.
00:42And that would hit Europe particularly hard.
00:45Ireland, Denmark and Germany are home to many pharma giants that make innovative patent-protected
00:52drugs and exports are a major chunk of their revenues.
00:57EU countries exported pharmaceuticals worth 313 billion euros last year and the US was
01:05their biggest market with exports worth 120 billion euros.
01:11Companies say research and development are expensive and that's why they have higher prices.
01:17But whether the 100% tariff will apply remains a question.
01:22The EU and the US reached a deal in July, setting 15% as the maximum tariff rate.
01:30The tariffs on pharmaceuticals would be a radical break to 30 years of trade policy.
01:37In 1995, the US, the EU and several other countries agreed to abolish import duties on pharmaceuticals
01:45for the good of the people.

Recommended